Laura Barnabei

4.7k total citations · 1 hit paper
12 papers, 546 citations indexed

About

Laura Barnabei is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Laura Barnabei has authored 12 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Genetics. Recurrent topics in Laura Barnabei's work include Lymphoma Diagnosis and Treatment (3 papers), interferon and immune responses (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Laura Barnabei is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), interferon and immune responses (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Laura Barnabei collaborates with scholars based in France, Switzerland and Italy. Laura Barnabei's co-authors include Frédéric Rieux‐Laucat, Robert Weil, Emmanuel Laplantine, Delphine Sterlin, Zahir Amoura, Alexis Mathian, Fleur Cohen‐Aubart, Flore Rozenberg, M. Pha and Hervé Devilliers and has published in prestigious journals such as Scientific Reports, Science Advances and Frontiers in Immunology.

In The Last Decade

Laura Barnabei

12 papers receiving 542 citations

Hit Papers

NF-κB: At the Borders of Autoimmunity and Inflammation 2021 2026 2022 2024 2021 100 200 300 400

Peers

Laura Barnabei
Laura Barnabei
Citations per year, relative to Laura Barnabei Laura Barnabei (= 1×) peers Flávio P. Veras

Countries citing papers authored by Laura Barnabei

Since Specialization
Citations

This map shows the geographic impact of Laura Barnabei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Barnabei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Barnabei more than expected).

Fields of papers citing papers by Laura Barnabei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Barnabei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Barnabei. The network helps show where Laura Barnabei may publish in the future.

Co-authorship network of co-authors of Laura Barnabei

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Barnabei. A scholar is included among the top collaborators of Laura Barnabei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Barnabei. Laura Barnabei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fusaro, Mathieu, Laura Barnabei, Quentin Riller, et al.. (2024). A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings. Clinical Immunology. 261. 110165–110165. 1 indexed citations
2.
Guidetti, Francesca, Alberto J. Arribas, Giulio Sartori, et al.. (2023). Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of Clinical Medicine. 12(2). 399–399. 10 indexed citations
3.
Stolzenberg, Marie‐Claude, Jérôme Hadjadj, Laura Barnabei, et al.. (2023). L’haploinsuffisance en SHARPIN est responsable d’un déficit partiel en LUBAC, de manifestations inflammatoires, d’une auto-immunité et d’un défaut de production d’anticorps. La Revue de Médecine Interne. 44. A329–A329. 1 indexed citations
4.
Ożyhar, Tomasz, et al.. (2022). When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic. Journal of Law and the Biosciences. 9(1). lsac004–lsac004. 1 indexed citations
5.
Barnabei, Laura, et al.. (2022). A DNA biosensors-based microfluidic platform for attomolar real-time detection of unamplified SARS-CoV-2 virus. Biosensors and Bioelectronics X. 13. 100302–100302. 9 indexed citations
6.
Sartori, Giulio, Sara Napoli, Luciano Cascione, et al.. (2021). ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma. Journal of Experimental & Clinical Cancer Research. 40(1). 357–357. 8 indexed citations
7.
Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations
8.
Barnabei, Laura, et al.. (2021). NF-κB: At the Borders of Autoimmunity and Inflammation. Frontiers in Immunology. 12. 716469–716469. 409 indexed citations breakdown →
9.
Guidetti, Francesca, Alberto J. Arribas, Filippo Spriano, et al.. (2021). Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P073–P073. 1 indexed citations
10.
Barnabei, Laura, et al.. (2020). Generation of an iPSC line (IMAGINi011-A) from a patient carrying a STING mutation. Stem Cell Research. 50. 102107–102107. 3 indexed citations
11.
Fernández-Pérez, Daniel, Alessandro d’Ambrosio, Caterina Barbieri, et al.. (2019). Loss of PRC1 activity in different stem cell compartments activates a common transcriptional program with cell type–dependent outcomes. Science Advances. 5(5). eaav1594–eaav1594. 21 indexed citations
12.
Mathian, Alexis, S. Mouriès-Martin, Karim Dorgham, et al.. (2018). Monitoring Disease Activity in Systemic Lupus Erythematosus With Single‐Molecule Array Digital Enzyme‐Linked Immunosorbent Assay Quantification of Serum Interferon‐α. Arthritis & Rheumatology. 71(5). 756–765. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026